Association of MHC class I related gene B (MICB) to celiac disease. 2004

Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
Department of Functional Biology, University of Oviedo, Spain.

OBJECTIVE Celiac disease (CD) is an enteropathic disorder characterized by strong association with HLA-DQ2. Our aim was to investigate whether MICB, a gene located in the MHC class I region, may contribute to CD susceptibility. METHODS Total of 133 CD patients, previously reported to be associated with MICA-A5.1, and 116 controls were initially analyzed. Twenty-eight additional DQ2-negative CD patients were also studied. MICB was typed by PCR using sequence-specific primers. HLA-B, -DRB1, -DQA1, -DQB1, and MICA were also typed. RESULTS The allele MICB0106 was strongly associated with CD (pc < 0.000001, odds ratio (OR) = 5.6, 95% confidence interval (CI) = 3.1-10.1) and it was overrepresented in atypical patients compared with typical ones (pc = 0.04, OR = 2.9, CI = 1.4-6.1). MICB0106 was part of DR3-DQ2 haplotype (B8-MICA-A5.1-MICB0106-DR3-DQ2), and consequently a strong linkage disequilibrium between MICB0106 with DQ2 (lambdas = 1) and MICA-A5.1 (lambdas = 0.55) was found. To analyze whether the association of MICB is independent of this haplotype, its association was also studied in DQ2-negative patients (n = 46). DQ8 (28%vs 9%, p = 0.0085, pc = NS) and MICB0104 (52%vs 30%, p = 0.01, pc = NS) were increased in DQ2-negative patients. MICA-A5.1 was significantly increased in atypical patients (p(c)= 0.001, OR = 6.4, CI = 2.2-18.4), and this association was independent of DQ2 and DQ8 (pc = 0.02, OR = 2.6, CI = 1.1-6.1). CONCLUSIONS The expression of MIC genes on enterocytes under stressful conditions and their function as ligands of intraepithelial gammadelta and CD8 T cells, together with the data presented here suggest a potential role of MIC genes in the pathogenesis of CD.

UI MeSH Term Description Entries
D008297 Male Males
D002446 Celiac Disease A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION. Gluten Enteropathy,Sprue, Celiac,Sprue, Nontropical,Celiac Sprue,Gluten-Sensitive Enteropathy,Sprue,Disease, Celiac,Enteropathies, Gluten,Enteropathies, Gluten-Sensitive,Enteropathy, Gluten,Enteropathy, Gluten-Sensitive,Gluten Enteropathies,Gluten Sensitive Enteropathy,Gluten-Sensitive Enteropathies,Nontropical Sprue
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
December 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
January 1997, Immunogenetics,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
March 2006, Human immunology,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
March 2007, Rheumatology (Oxford, England),
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
April 2003, Tissue antigens,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
June 1998, Tissue antigens,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
January 1996, Immunogenetics,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
April 2006, Transplantation,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
June 2008, Biochemical and biophysical research communications,
Segundo González, and Luis Rodrigo, and Antonio López-Vázquez, and Dolores Fuentes, and Lorena Agudo-Ibáñez, and Sandra Rodríguez-Rodero, and Juan Luis Fdez-Morera, and Jesús Martínez-Borra, and Carlos López-Larrea
January 1996, Immunogenetics,
Copied contents to your clipboard!